Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acutus Medical, Inc.AFIB · Entity 83848 | Director | June 16, 2022 | June 21, 2022 |
| Integer Holdings CorpITGR · Entity 4016 | Director | May 20, 2026 | May 22, 2026 |
| Orthofix Medical Inc.OFIX · Entity 1975 | Director | September 14, 2023 | September 14, 2023 |
| Outset Medical, Inc.OM · Entity 7026 | Director | May 29, 2024 | May 29, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acutus Medical, Inc.
Report date June 16, 2022 · Filed June 21, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,311 |
Reported balance
After 2022-06-16 transaction · row 1
1 source rowRow 1 · 2022-06-16 · Grant · Acquired 8,400 · Balance 61,311 F1: Each annual restricted stock unit ("Annual RSU") will be scheduled to vest as to all of the shares of Common Stock ("Shares") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the reporting person has remained in continuous service as a director. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.50 · Expires 2032-06-16 | Direct | 19,600 |
Reported balance
After 2022-06-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-06-16 · Grant · Acquired 19,600 · Balance 19,600 F2: Each annual stock option (the "Annual Option") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the reporting person has remained in continuous service as a director. |
| Common StockSEC Table I · non-derivative | IndirectBy Hinrichs Joint Revocable Trust | 14,999 |
Reported balance
Holding disclosure · report date 2022-06-16 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 14,999 |
Filing footnotes · ownership attribution and instrument terms
F1: Each annual restricted stock unit ("Annual RSU") will be scheduled to vest as to all of the shares of Common Stock ("Shares") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the reporting person has remained in continuous service as a director.
F2: Each annual stock option (the "Annual Option") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the reporting person has remained in continuous service as a director.
Integer Holdings Corp
Report date May 20, 2026 · Filed May 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,967 |
Reported balance
After 2026-05-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,967 · Balance 1,967 F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2: Grant of RSUs as of May 20, 2026. RSUs vest in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2: Grant of RSUs as of May 20, 2026. RSUs vest in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer.
Orthofix Medical Inc.
Report date September 14, 2023 · Filed September 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 86,153 |
Reported balance
After 2023-09-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-09-14 · Purchase · Acquired 7,500 · Balance 86,153 F1: Reflects the weighted average purchase price. The range of prices for these transactions was $13.46 to $13.48. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. F2: Includes 39,548 deferred stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the weighted average purchase price. The range of prices for these transactions was $13.46 to $13.48. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
F2: Includes 39,548 deferred stock units.
Outset Medical, Inc.
Report date May 29, 2024 · Filed May 29, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 80,349 |
Reported balance
After 2024-05-29 transaction · row 1
1 source rowRow 1 · 2024-05-29 · Grant · Acquired 25,000 · Balance 80,349 F1: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders |
Filing footnotes · ownership attribution and instrument terms
F1: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ALERE INC.
Report date October 03, 2017 · Filed October 03, 2017
Section 16 reporting ended · disclosed 2017-10-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-10-03 transaction · row 1
1 source rowRow 1 · 2017-10-03 · Disposition to issuer · Disposed 72,230 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration"). |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.48 | Direct | 0 |
Reported balance
After 2017-10-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-10-03 · Disposition to issuer · Disposed 108,118 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.08 | Direct | 0 |
Reported balance
After 2017-10-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-10-03 · Disposition to issuer · Disposed 250,000 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-10-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-10-03 · Disposition to issuer · Disposed 44,350 · Balance 0 F3: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.
F3: Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Pursuant to the Merger Agreement, at the Effective Time, each outstanding Restricted Stock Unit was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock subject to such Restricted Stock Unit immediately prior to the Effective Time and (ii) the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2026 Filed May 22, 2026 20:52 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantRestricted Stock Units · Derivative | 1,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001506974-26-000002 · wk-form4_1779483169.xml · derivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,967 Underlying: Common Stock · 1,967 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Grant of RSUs as of May 20, 2026. RSUs vest in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. F2 · derivative.expiration_date: Grant of RSUs as of May 20, 2026. RSUs vest in approximately equal installments on August 20, 2026, November 20, 2026, February 20, 2027, and May 18, 2027. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:46 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantRestricted Stock Units · Derivative | 1,514 | $0.00 | $0.00 |
DisclosureSEC source: 0001114483-25-000107 · wk-form4_1748033208.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,514 Underlying: Common Stock · 1,514 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Grant of RSUs as of May 21, 2025. RSUs vest in approximately equal installments on August 21, 2025, November 21, 2025, February 21, 2026 and May 19, 2026. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. F2 · derivative.expiration_date: Grant of RSUs as of May 21, 2025. RSUs vest in approximately equal installments on August 21, 2025, November 21, 2025, February 21, 2026 and May 19, 2026. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. Read SEC document |
| May 29, 2024 Filed May 29, 2024 23:11 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-24-000053 · edgardoc.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,349 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 24, 2024 Filed May 28, 2024 19:20 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionStock Option · Derivative | 7,648 | $0.00 Strike: $44.60 | $0.00 |
DisclosureSEC source: 0000950170-24-065109 · ownership.xml · derivative · entry 5 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,648 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Grant of non-qualified stock options that vested in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. Read SEC document |
| May 24, 2024 Filed May 28, 2024 19:20 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionStock Option · Derivative | 1,955 | $0.00 Strike: $44.60 | $0.00 |
DisclosureSEC source: 0000950170-24-065109 · ownership.xml · derivative · entry 4 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,955 shares Expires 2028-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Grant of non-qualified stock options of which 355 options vested on February 12, 2018 and the remaining options vested in three equal installments on April 2, 2018, July 2, 2018 and October 1, 2018. Read SEC document |
| May 24, 2024 Filed May 28, 2024 19:20 UTC | Integer Holdings Corp ITGR · Entity 4016 | SaleCommon Stock | 9,603 | $122.44 | $1,175,772.11 |
DisclosureSEC source: 0000950170-24-065109 · ownership.xml · nonDerivative · entry 3 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,424 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at multiple prices ranging from $122.00 to $122.90, inclusive. The reporting person undertakes to provide to Integer Holdings Corp, any security holder of Integer Holdings Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| May 24, 2024 Filed May 28, 2024 19:20 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionCommon Stock | 7,648 | $44.60 | $341,100.80 |
DisclosureSEC source: 0000950170-24-065109 · ownership.xml · nonDerivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2024 Filed May 28, 2024 19:20 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionCommon Stock | 1,955 | $44.60 | $87,193.00 |
DisclosureSEC source: 0000950170-24-065109 · ownership.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,379 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2024 Filed May 23, 2024 21:33 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantRestricted Stock Units · Derivative | 1,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001114483-24-000088 · wk-form4_1716499995.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,480 Underlying: Common Stock · 1,480 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Grant of RSUs as of May 22, 2024. RSUs vest in equal installments on August 22, 2024, November 22, 2024, February 22, 2025 and May 20, 2025. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. F2 · derivative.expiration_date: Grant of RSUs as of May 22, 2024. RSUs vest in equal installments on August 22, 2024, November 22, 2024, February 22, 2025 and May 20, 2025. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. Read SEC document |
| September 14, 2023 Filed Sep 14, 2023 21:15 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | PurchaseCommon Stock | 7,500 | $13.47 | $101,025.00 |
DisclosureSEC source: 0001209191-23-049458 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,153 F1 · price: Reflects the weighted average purchase price. The range of prices for these transactions was $13.46 to $13.48. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide, upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: Includes 39,548 deferred stock units. Read SEC document |
| May 31, 2023 Filed May 31, 2023 23:04 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 7,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-23-000044 · edgardoc.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,349 F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 24, 2023 Filed May 26, 2023 10:00 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantRestricted Stock Units · Derivative | 2,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-032359 · doc4.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,246 Underlying: Common · 2,246 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Grant of RSUs as of May 24, 2023. RSUs vest in equal installments on August 24, 2023, November 24, 2023, February 24, 2024 and May 21, 2024. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. F2 · derivative.expiration_date: Grant of RSUs as of May 24, 2023. RSUs vest in equal installments on August 24, 2023, November 24, 2023, February 24, 2024 and May 21, 2024. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. Read SEC document |
| January 05, 2023 Filed Jan 10, 2023 00:05 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002658 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,557 F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023. F2 · balance_after: Includes 39,246 deferred stock units. Read SEC document |
| January 05, 2023 Filed Feb 9, 2023 23:03 UTC Amendment | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 14,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-008134 · doc4a.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,859 F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders. F2 · shares: This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023. F3 · balance_after: Includes 39,548 deferred stock units. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 00:15 UTC | Outset Medical, Inc. OM · Entity 7026 | PurchaseCommon Stock | 7,500 | $17.84 | $133,800.00 |
DisclosureSEC source: 0001484612-22-000080 · edgardoc.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,668 F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were purchased in multiple transactions at prices ranging from: $17.76 - $17.90 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: These shares of common stock of the Issuer ("Shares"), purchased on November 22, 2022, are held directly by James Hinrichs IRA Rollover, Charles Schwab & Co Inc Custodian. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:45 UTC | Acutus Medical, Inc. AFIB · Entity 83848 | GrantStock Options (Right to Buy) · Derivative | 19,600 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0000950103-22-010955 · dp175623_4-hinrichs.xml · derivative · entry 3 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,600 Underlying: Common Stock · 19,600 shares Expires 2032-06-16 F2 · derivative.exercise_date: Each annual stock option (the "Annual Option") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the reporting person has remained in continuous service as a director. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 21:45 UTC | Acutus Medical, Inc. AFIB · Entity 83848 | GrantCommon Stock | 8,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-22-010955 · dp175623_4-hinrichs.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,311 F1 · shares: Each annual restricted stock unit ("Annual RSU") will be scheduled to vest as to all of the shares of Common Stock ("Shares") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the reporting person has remained in continuous service as a director. Read SEC document |
| June 06, 2022 Filed Jun 8, 2022 20:32 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 6,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035044 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,727 F1 · shares: Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 20:24 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 6,880 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-22-000047 · edgardoc.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,168 F1 · kind: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 18, 2022 Filed May 19, 2022 21:00 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantRestricted Stock Units · Derivative | 2,277 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-030575 · doc4.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,277 Underlying: Common · 2,277 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Grant of RSUs as of May 18, 2022. RSUs vest in equal installments on August 18, 2022, November 18, 2022, February 18, 2023 and May 16, 2023. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. F2 · derivative.expiration_date: Grant of RSUs as of May 18, 2022. RSUs vest in equal installments on August 18, 2022, November 18, 2022, February 18, 2023 and May 16, 2023. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 21:45 UTC | Acutus Medical, Inc. AFIB · Entity 83848 | PurchaseCommon Stock | 40,000 | $3.78 | $151,220.00 |
DisclosureSEC source: 0000950103-21-017999 · dp161919_4-hinrichs.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,911 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.7450 to $3.7950, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 20:49 UTC | Outset Medical, Inc. OM · Entity 7026 | PurchaseCommon Stock | 10,000 | $36.66 | $366,600.00 |
DisclosureSEC source: 0001484612-21-000052 · edgardoc.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,288 F1 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were purchased by the reporting person in multiple open market transactions at prices ranging from $36.20 to $37.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased within the range set forth in this footnote. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:25 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 4,313 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-042740 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,594 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 21, 2021. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:28 UTC | Acutus Medical, Inc. AFIB · Entity 83848 | GrantStock Options (Right to Buy) · Derivative | 7,022 | $0.00 Strike: $16.66 | $0.00 |
DisclosureSEC source: 0000950103-21-009196 · dp152983_4-hinrichs.xml · derivative · entry 3 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,022 Underlying: Common Stock · 7,022 shares Expires 2031-06-17 F2 · derivative.exercise_date: Each annual stock option (the "Annual Option") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the reporting person has remained in continuous service as a director. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 21:28 UTC | Acutus Medical, Inc. AFIB · Entity 83848 | GrantCommon Stock | 1,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-21-009196 · dp152983_4-hinrichs.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,911 F1 · shares: Each annual restricted stock unit ("Annual RSU") will be scheduled to vest as to all of the shares of Common Stock ("Shares") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the reporting person has remained in continuous service as a director. Read SEC document |
| June 03, 2021 Filed Jun 4, 2021 21:04 UTC | Outset Medical, Inc. OM · Entity 7026 | GrantCommon Stock | 3,288 | $0.00 | $0.00 |
DisclosureSEC source: 0001484612-21-000022 · edgardoc.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,288 F1 · shares: 100% of the shares underlying these RSUs will vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the Issuer's next Annual Meeting of Stockholders Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:01 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantRestricted Stock Units · Derivative | 1,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034472 · doc4.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,820 Underlying: Common · 1,820 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Grant of RSUs as of May 19, 2021. RSUs vest in equal installments on August 19, 2021, November 19, 2021, February 21, 2022 and May 17, 2022. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. F2 · derivative.expiration_date: Grant of RSUs as of May 19, 2021. RSUs vest in equal installments on August 19, 2021, November 19, 2021, February 21, 2022 and May 17, 2022. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. Read SEC document |
| September 17, 2020 Filed Sep 18, 2020 00:15 UTC | Outset Medical, Inc. OM · Entity 7026 | PurchaseCommon Stock | 20,000 | $27.00 | $540,000.00 |
DisclosureSEC source: 0001140361-20-020787 · form4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| August 10, 2020 Filed Aug 13, 2020 01:47 UTC | Acutus Medical, Inc. AFIB · Entity 83848 | PurchaseCommon Stock | 10,000 | $18.00 | $180,000.00 |
DisclosureSEC source: 0000950103-20-015726 · dp134370_4-hinrichs.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,111 Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:51 UTC | Acutus Medical, Inc. AFIB · Entity 83848 | GrantStock Options (Right to Buy) · Derivative | 6,227 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000950103-20-015479 · dp134111_4-hinrichs.xml · derivative · entry 3 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,227 Underlying: Common Stock · 6,227 shares Expires 2030-08-05 F1 · derivative.exercise_date: This option begins vesting on August 5, 2020, and vests in full on the first anniversary of the vesting commencement date, subject to continued service through each such vesting date. Read SEC document |
| August 05, 2020 Filed Aug 7, 2020 23:51 UTC | Acutus Medical, Inc. AFIB · Entity 83848 | GrantCommon Stock | 1,111 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-20-015479 · dp134111_4-hinrichs.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,111 Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 22:06 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 4,588 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-035663 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,514 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 8, 2020. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:00 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantRestricted Stock Units · Derivative | 2,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031685 · doc4.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,920 Underlying: Common Stock · 2,920 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Grant of RSUs as of May 20, 2020. RSUs vest in equal installments on August 1, 2020, November 20, 2020, February 20, 2021 and May 18, 2021. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. F2 · derivative.expiration_date: Grant of RSUs as of May 20, 2020. RSUs vest in equal installments on August 1, 2020, November 20, 2020, February 20, 2021 and May 18, 2021. The RSUs will convert into common stock on a one-for-one basis, but the Reporting Person has elected to defer settlement of the common stock underlying these RSUs until separation from service as a director, or a change in control, of the Issuer. Read SEC document |
| March 12, 2020 Filed Mar 16, 2020 11:05 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | PurchaseCommon Stock | 10,000 | $26.85 | $268,469.00 |
DisclosureSEC source: 0001209191-20-019080 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,574 F1 · shares: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.58 to $27.23, inclusive. The reporting person undertakes to provide Orthofix Medical Inc., any security holder of Orthofix Medical Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| September 28, 2019 Filed Oct 1, 2019 19:39 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionRestricted Stock Units · Derivative | 438 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-051253 · doc4.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 438 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Vesting of restricted stock units granted on January 2, 2019. F2 · derivative.expiration_date: Vesting of restricted stock units granted on January 2, 2019. Read SEC document |
| September 28, 2019 Filed Oct 1, 2019 19:39 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionCommon Stock | 438 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-051253 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| September 12, 2019 Filed Sep 13, 2019 20:02 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GiftCommon Stock | 1,975 | $51.99 | $102,680.25 |
DisclosureSEC source: 0001209191-19-049463 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,023 Read SEC document |
| June 29, 2019 Filed Jul 1, 2019 19:21 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionRestricted Stock Units · Derivative | 437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-039632 · doc4.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 438 Underlying: Common · 437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Vesting of restricted stock units granted on January 2, 2019. F2 · derivative.expiration_date: Vesting of restricted stock units granted on January 2, 2019. Read SEC document |
| June 29, 2019 Filed Jul 1, 2019 19:21 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionCommon Stock | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-039632 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 21:55 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 3,431 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-036903 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,998 F1 · shares: Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The award vests in full on the first anniversary of the grant date, June 11, 2019. Read SEC document |
| May 23, 2019 Filed May 28, 2019 18:26 UTC | Integer Holdings Corp ITGR · Entity 4016 | PurchaseCommon Stock | 3,750 | $68.47 | $256,762.50 |
DisclosureSEC source: 0001209191-19-032924 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,549 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at multiple prices ranging from $68.43 to $68.50, inclusive. The reporting person undertakes to provide to Integer Holdings Corp, any security holder of Integer Holdings Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| March 30, 2019 Filed Apr 1, 2019 18:41 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionRestricted Stock Units · Derivative | 437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021924 · doc4.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 875 Underlying: Common · 437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Vesting of restricted stock units granted on January 2, 2019. F2 · derivative.expiration_date: Vesting of restricted stock units granted on January 2, 2019. Read SEC document |
| March 30, 2019 Filed Apr 1, 2019 18:41 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionCommon Stock | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021924 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,799 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:29 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionRestricted Stock Units · Derivative | 437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-000976 · doc4.xml · derivative · entry 3 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,312 Underlying: Common · 437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Grant of restricted stock units as of January 2, 2019. 25% of such restricted stock units vest on January 2, 2019, and the remainder vest in substantially equal installments on the first day of each remaining fiscal quarter in 2019. F2 · derivative.expiration_date: Grant of restricted stock units as of January 2, 2019. 25% of such restricted stock units vest on January 2, 2019, and the remainder vest in substantially equal installments on the first day of each remaining fiscal quarter in 2019. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:29 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantRestricted Stock Units · Derivative | 1,749 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-000976 · doc4.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,749 Underlying: Common · 1,749 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: Grant of restricted stock units as of January 2, 2019. 25% of such restricted stock units vest on January 2, 2019, and the remainder vest in substantially equal installments on the first day of each remaining fiscal quarter in 2019. F2 · derivative.expiration_date: Grant of restricted stock units as of January 2, 2019. 25% of such restricted stock units vest on January 2, 2019, and the remainder vest in substantially equal installments on the first day of each remaining fiscal quarter in 2019. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:29 UTC | Integer Holdings Corp ITGR · Entity 4016 | Exercise / conversionCommon Stock | 437 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-000976 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| July 17, 2018 Filed Jul 17, 2018 22:59 UTC | Orthofix Medical Inc. OFIX · Entity 1975 | GrantCommon Stock | 2,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042912 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,197 F1 · shares: Deferred Stock Unit award granted on July 2, 2018, subject to shareholder approval, which was obtained on July 17, 2018, and is subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These awards vest in full on July 2, 2019. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 21:10 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantNon-Qualified Stock Options · Derivative | 7,648 | $0.00 Strike: $44.60 | $0.00 |
DisclosureSEC source: 0001209191-18-009956 · doc4.xml · derivative · entry 3 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,648 Underlying: Common · 7,648 shares Expires 2028-02-12 F3 · derivative.exercise_date: Grant of non-qualified stock options that vest in three equal annual installments on the last day of each fiscal year beginning in fiscal year 2018. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 21:10 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantNon-Qualified Stock Options · Derivative | 1,955 | $0.00 Strike: $44.60 | $0.00 |
DisclosureSEC source: 0001209191-18-009956 · doc4.xml · derivative · entry 2 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,955 Underlying: Common · 1,955 shares Expires 2028-02-12 F2 · derivative.exercise_date: Grant of non-qualified stock options of which 355 options vest immediately and the remaining options will vest in three equal installments on April 2, 2018, July 2, 2018 and October 1, 2018. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 21:10 UTC | Integer Holdings Corp ITGR · Entity 4016 | GrantCommon Stock | 1,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-009956 · doc4.xml · nonDerivative · entry 1 Hinrichs James F. · CIK 0001506974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,925 F1 · shares: Grant of restricted stock of which 350 shares vest immediately and the remaining shares will vest in three equal installments on April 2, 2018, July 2, 2018 and October 1, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.